Admittance provides a platform technology compatible with all existing pacemakers that uses Admittance to determine heart volume in real time. Early detection of heart failure through left ventricular (LV) end-diastolic volume, pacemaker optimization using previously implanted pacemaker bi-ventricular leads through LV stroke volume (SV), and determining whether life ending arrhythmias such as ventricular tachycardia need to be shocked thought LV SV, have all become possible using scientific breakthroughs discovered by Admittance Technologies. CardioVol™, our flagship product, is ahead of the curve in three areas by providing: 1) the only device which can determine the hemodynamic stability of ventricular tachycardia, 2) the only available therapy to tune the timing of pacemakers previously implanted in these patients, 3) the earliest detection of impending heart failure, and 4) technology that requires no additional surgery because we are piggybacking into devices already indicated in all patients with weakened hearts.
Company Details
- Founded
- -
- Address
- Austin, Tx
- Phone
- 5123501187
- Industry
- Medical Device
- Website
- admittancetechnologies.com
- Keywords
- IT Consulting.
- HQ
- Austin, TX
Admittance Technologies, Inc. Questions
Admittance Technologies, Inc.'s helpline number is 5123501187
Admittance Technologies, Inc.'s website is admittancetechnologies.com
Admittance Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/admittance-technologies-inc-
Admittance Technologies, Inc.'s industry is
Medical Device
Admittance Technologies, Inc.'s top competitors are
Nihon Kohden India,
Dozee,
Transasia Bio-Medicals Ltd.,
Bi̇tes - Defence & Aerospace Technologies,
Mistral Solutions,
Emyosound.
Admittance Technologies, Inc.'s categories are Medical Device
Admittance Technologies, Inc.'s founding year is 2010
